vanda pharmaceuticals inc
(VNDA:Consolidated Issue listed on NASDAQ Global Market)
James Patrick Kelly
Chief Financial Officer, Principal Accounting Officer, Senior Vice President, Treasurer and Secretary, Vanda Pharmaceuticals, Inc.
|Age||Total Calculated Compensation||This person is connected to 0 board members in 0 different organizations across 1 different industries.|
As of Fiscal Year 2014
Mr. James Patrick Kelly, also known as Jim, has been the Chief Financial Officer, Senior Vice President, Secretary and Treasurer at Vanda Pharmaceuticals, Inc. since December 13, 2010 and also serves as its Principal Accounting Officer. Mr. Kelly has more than 18 years of experience in financial and operating roles within the healthcare and pharmaceutical industry. He has been a key member of MedImmune's financial leadership team since 2006. He joined MedImmune LLC., ...
2200 Pennsylvania Avenue NWPhone: 202-734-3400
Washington, District Of Columbia 20037
Board Members Memberships*There is no Board Members Memberships data available.
The University of Vermont
|Giovanni Caforio M.D.||Chief Executive Officer, Chief Operating Officer and Director|
Bristol-Myers Squibb Company
|John C. Lechleiter Ph.D.||Chairman, Chief Executive Officer and President|
Eli Lilly and Company
|Pascal Soriot||Chief Executive Officer, Executive Director and Member of Disclosure Committee|
|Olivier Brandicourt||Chief Executive Officer and Director|
|Douglas L. Drysdale||Chairman, Chief Executive Officer and President|
Pernix Therapeutics Holdings, Inc.
|--||Compensation as of Fiscal Year 2014.|